nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—CYP1A2—Betaxolol—glaucoma	0.172	0.264	CbGbCtD
Niclosamide—CYP2C9—Diclofenamide—glaucoma	0.137	0.209	CbGbCtD
Niclosamide—CYP2C9—Dorzolamide—glaucoma	0.132	0.202	CbGbCtD
Niclosamide—CYP2C9—Methazolamide—glaucoma	0.118	0.18	CbGbCtD
Niclosamide—CYP1A2—Clonidine—glaucoma	0.0944	0.145	CbGbCtD
Niclosamide—STAT3—endothelium—glaucoma	0.0138	0.408	CbGeAlD
Niclosamide—STAT3—eye—glaucoma	0.00675	0.2	CbGeAlD
Niclosamide—STAT3—retina—glaucoma	0.00669	0.198	CbGeAlD
Niclosamide—STAT3—connective tissue—glaucoma	0.00651	0.193	CbGeAlD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—HDAC9—glaucoma	0.0034	0.011	CbGpPWpGaD
Niclosamide—STAT3—IL-7 Signaling Pathway—BCL2L1—glaucoma	0.00334	0.0108	CbGpPWpGaD
Niclosamide—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00311	0.01	CbGpPWpGaD
Niclosamide—STAT3—IL-2 Signaling Pathway—CCND2—glaucoma	0.00307	0.00989	CbGpPWpGaD
Niclosamide—STAT3—IL-7 Signaling Pathway—BAD—glaucoma	0.00303	0.00976	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—HDAC9—glaucoma	0.00294	0.00947	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—NTRK2—glaucoma	0.00272	0.00875	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—FGFR1OP—glaucoma	0.0026	0.00836	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—NCK2—glaucoma	0.00252	0.0081	CbGpPWpGaD
Niclosamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.0025	0.00805	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—CAV2—glaucoma	0.00248	0.00799	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—NGFR—glaucoma	0.00233	0.00751	CbGpPWpGaD
Niclosamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00228	0.00733	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NCK2—glaucoma	0.00225	0.00723	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—NTRK1—glaucoma	0.00222	0.00713	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—BCL2L1—glaucoma	0.00217	0.00698	CbGpPWpGaD
Niclosamide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00214	0.00688	CbGpPWpGaD
Niclosamide—STAT3—IL-7 Signaling Pathway—CDKN1B—glaucoma	0.00211	0.0068	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—NCK2—glaucoma	0.00205	0.00662	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—NCK2—glaucoma	0.00204	0.00658	CbGpPWpGaD
Niclosamide—STAT3—ErbB2/ErbB3 signaling events—BAD—glaucoma	0.00204	0.00657	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—BDNF—glaucoma	0.00203	0.00653	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—SOD1—glaucoma	0.00203	0.00653	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—BCL2L1—glaucoma	0.00202	0.0065	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—BAD—glaucoma	0.00196	0.00632	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—BCL2L1—glaucoma	0.00195	0.00629	CbGpPWpGaD
Niclosamide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00194	0.00626	CbGpPWpGaD
Niclosamide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.0019	0.00612	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—NCK2—glaucoma	0.00186	0.006	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—NGF—glaucoma	0.0018	0.0058	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—CAV1—glaucoma	0.00179	0.00578	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—BAD—glaucoma	0.00177	0.0057	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—BAD—glaucoma	0.00171	0.00552	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—BAD—glaucoma	0.00164	0.00527	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TXN—glaucoma	0.00161	0.00518	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—MMP1—glaucoma	0.00157	0.00504	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—BAD—glaucoma	0.00153	0.00491	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—EDN1—glaucoma	0.00152	0.00488	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—TNF—glaucoma	0.00146	0.0047	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00145	0.00466	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—RPTOR—glaucoma	0.00143	0.0046	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—FN1—glaucoma	0.00139	0.00449	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—BCL2L1—glaucoma	0.00139	0.00447	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—BAD—glaucoma	0.00138	0.00444	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NTRK2—glaucoma	0.00137	0.0044	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—CDKN2B—glaucoma	0.00132	0.00426	CbGpPWpGaD
Niclosamide—STAT3—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.00127	0.0041	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL1A—glaucoma	0.00126	0.00406	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—BAD—glaucoma	0.00126	0.00405	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL1A—glaucoma	0.00123	0.00397	CbGpPWpGaD
Niclosamide—Diflunisal—PTGS2—glaucoma	0.00123	0.529	CrCbGaD
Niclosamide—STAT3—Cellular responses to stress—TXN—glaucoma	0.00121	0.00391	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by TCPTP—VEGFA—glaucoma	0.00121	0.00388	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—MMP2—glaucoma	0.0012	0.00385	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NGFR—glaucoma	0.00117	0.00378	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—CAV1—glaucoma	0.00117	0.00376	CbGpPWpGaD
Niclosamide—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.00116	0.00372	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—BAD—glaucoma	0.00115	0.0037	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—NOS3—glaucoma	0.00112	0.00361	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.00112	0.0036	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NTRK1—glaucoma	0.00111	0.00359	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—TNF—glaucoma	0.0011	0.00354	CbGpPWpGaD
Niclosamide—Meclofenamic acid—PTGS2—glaucoma	0.0011	0.471	CrCbGaD
Niclosamide—STAT3—ErbB1 downstream signaling—BCL2L1—glaucoma	0.00106	0.00342	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—MMP9—glaucoma	0.00106	0.0034	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—NTRK2—glaucoma	0.00103	0.00331	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—BDNF—glaucoma	0.00102	0.00329	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—NOS3—glaucoma	0.00101	0.00326	CbGpPWpGaD
Niclosamide—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000987	0.00318	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—CDKN1B—glaucoma	0.000983	0.00316	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—NR3C1—glaucoma	0.000978	0.00315	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—CDKN1B—glaucoma	0.000971	0.00313	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—BAD—glaucoma	0.000962	0.0031	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—FAS—glaucoma	0.000948	0.00305	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NGF—glaucoma	0.000906	0.00292	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—MMP9—glaucoma	0.000899	0.0029	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000893	0.00287	CbGpPWpGaD
Niclosamide—STAT3—Disease—LRP12—glaucoma	0.000842	0.00271	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NCK2—glaucoma	0.000838	0.0027	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—NTRK1—glaucoma	0.000837	0.00269	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDKN2B—glaucoma	0.000837	0.00269	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—VEGFA—glaucoma	0.000817	0.00263	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TNF—glaucoma	0.000813	0.00262	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL1A—glaucoma	0.000798	0.00257	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NTRK2—glaucoma	0.00079	0.00254	CbGpPWpGaD
Niclosamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000786	0.00253	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000763	0.00246	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—BAD—glaucoma	0.00076	0.00245	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—glaucoma	0.000756	0.00243	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—BAD—glaucoma	0.000747	0.0024	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—MMP9—glaucoma	0.000742	0.00239	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—CAV1—glaucoma	0.000723	0.00233	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—BAD—glaucoma	0.000683	0.0022	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.00068	0.00219	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NGFR—glaucoma	0.000678	0.00218	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000671	0.00216	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—glaucoma	0.00067	0.00216	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—SOD1—glaucoma	0.000669	0.00215	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—TNF—glaucoma	0.00066	0.00213	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NTRK1—glaucoma	0.000644	0.00207	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—BAD—glaucoma	0.000633	0.00204	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN2B—glaucoma	0.000632	0.00204	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—BAD—glaucoma	0.000619	0.00199	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000618	0.00199	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000617	0.00199	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL1A—glaucoma	0.000603	0.00194	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000603	0.00194	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LRP12—glaucoma	0.000589	0.0019	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000577	0.00186	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000576	0.00185	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000571	0.00184	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTSA—glaucoma	0.000569	0.00183	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000561	0.00181	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—NOS3—glaucoma	0.000547	0.00176	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PAX6—glaucoma	0.000543	0.00175	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGFR1OP—glaucoma	0.000542	0.00175	CbGpPWpGaD
Niclosamide—STAT3—Disease—HEYL—glaucoma	0.000542	0.00175	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000529	0.0017	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000527	0.0017	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000527	0.0017	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000527	0.0017	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NGF—glaucoma	0.000523	0.00168	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000502	0.00161	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000499	0.00161	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000493	0.00159	CbGpPWpGaD
Niclosamide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000492	0.00158	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—MMP9—glaucoma	0.00049	0.00158	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TXNIP—glaucoma	0.000479	0.00154	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDKN2A—glaucoma	0.000479	0.00154	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—CDKN1B—glaucoma	0.000476	0.00153	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TBK1—glaucoma	0.00047	0.00151	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000441	0.00142	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—BAD—glaucoma	0.000431	0.00139	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CDKN1B—glaucoma	0.000431	0.00139	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000426	0.00137	CbGpPWpGaD
Niclosamide—STAT3—Immune System—C1QB—glaucoma	0.000425	0.00137	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDKN1B—glaucoma	0.000424	0.00136	CbGpPWpGaD
Niclosamide—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000421	0.00135	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—OPN4—glaucoma	0.000408	0.00132	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000404	0.0013	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TNF—glaucoma	0.000402	0.0013	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000394	0.00127	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000391	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HEYL—glaucoma	0.00038	0.00122	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TXN—glaucoma	0.000378	0.00122	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTGFR—glaucoma	0.000368	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN2A—glaucoma	0.000362	0.00116	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000346	0.00111	CbGpPWpGaD
Niclosamide—STAT3—Disease—HDAC9—glaucoma	0.000338	0.00109	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN1B—glaucoma	0.00032	0.00103	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CDKN1B—glaucoma	0.0003	0.000967	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RPTOR—glaucoma	0.000288	0.000927	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NCK2—glaucoma	0.000279	0.000897	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.00027	0.000868	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—VEGFA—glaucoma	0.000266	0.000858	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—glaucoma	0.000266	0.000858	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.00026	0.000837	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000251	0.000808	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP2—glaucoma	0.000239	0.00077	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000238	0.000765	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HDAC9—glaucoma	0.000237	0.000763	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.00023	0.000742	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000225	0.000725	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000225	0.000725	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000222	0.000716	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000215	0.000692	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000212	0.000682	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—glaucoma	0.000201	0.000648	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000201	0.000646	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CA5A—glaucoma	0.000189	0.000608	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NARFL—glaucoma	0.000189	0.000608	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1A—glaucoma	0.000188	0.000605	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000187	0.000603	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SMO—glaucoma	0.000185	0.000597	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000184	0.000591	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN2B—glaucoma	0.000182	0.000586	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000181	0.000583	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—glaucoma	0.00018	0.000579	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000172	0.000553	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000171	0.000552	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NTRK2—glaucoma	0.00017	0.000546	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.000169	0.000545	CbGpPWpGaD
Niclosamide—STAT3—Immune System—C3—glaucoma	0.000165	0.000532	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NARFL—glaucoma	0.000161	0.00052	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CA5A—glaucoma	0.000161	0.00052	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—glaucoma	0.000161	0.00052	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00016	0.000516	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00016	0.000516	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BCL2L1—glaucoma	0.000158	0.000509	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTHFR—glaucoma	0.000153	0.000491	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTM1—glaucoma	0.000147	0.000472	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NGFR—glaucoma	0.000146	0.000469	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	0.000145	0.000466	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BAD—glaucoma	0.000143	0.000461	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOE—glaucoma	0.000142	0.000457	CbGpPWpGaD
Niclosamide—STAT3—Disease—CAV1—glaucoma	0.000141	0.000453	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—glaucoma	0.000138	0.000445	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NTRK1—glaucoma	0.000138	0.000445	CbGpPWpGaD
Niclosamide—STAT3—Disease—BAD—glaucoma	0.000132	0.000426	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN2B—glaucoma	0.000127	0.00041	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EDN1—glaucoma	0.000122	0.000394	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NGF—glaucoma	0.000112	0.000362	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—C3—glaucoma	0.000107	0.000344	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS3—glaucoma	0.000106	0.000343	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDKN1B—glaucoma	9.98e-05	0.000321	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOE—glaucoma	9.94e-05	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CAV1—glaucoma	9.85e-05	0.000317	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTGS2—glaucoma	9.73e-05	0.000313	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FN1—glaucoma	9.38e-05	0.000302	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—BAD—glaucoma	9.27e-05	0.000298	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CA1—glaucoma	9.23e-05	0.000297	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN1B—glaucoma	9.22e-05	0.000297	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CTSA—glaucoma	8.94e-05	0.000288	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CA2—glaucoma	8.44e-05	0.000272	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.25e-05	0.000266	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.25e-05	0.000266	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CA1—glaucoma	7.88e-05	0.000254	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CTSA—glaucoma	7.64e-05	0.000246	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOS3—glaucoma	7.45e-05	0.00024	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CA2—glaucoma	7.21e-05	0.000232	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.05e-05	0.000227	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.05e-05	0.000227	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN1B—glaucoma	6.45e-05	0.000208	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—glaucoma	5.98e-05	0.000192	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TXN—glaucoma	5.95e-05	0.000191	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.43e-05	0.000175	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.38e-05	0.000173	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—glaucoma	5.37e-05	0.000173	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TXN—glaucoma	5.08e-05	0.000164	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.64e-05	0.000149	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTT1—glaucoma	4.61e-05	0.000148	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.59e-05	0.000148	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—glaucoma	4.06e-05	0.000131	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTT1—glaucoma	3.94e-05	0.000127	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.72e-05	0.00012	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1B1—glaucoma	3.67e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCA1—glaucoma	3.67e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.18e-05	0.000102	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP1B1—glaucoma	3.14e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCA1—glaucoma	3.14e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTM1—glaucoma	2.94e-05	9.45e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—glaucoma	2.6e-05	8.36e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTM1—glaucoma	2.51e-05	8.08e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOE—glaucoma	2.42e-05	7.78e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAV1—glaucoma	2.39e-05	7.71e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—glaucoma	2.22e-05	7.14e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOE—glaucoma	2.06e-05	6.65e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAV1—glaucoma	2.05e-05	6.59e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NOS3—glaucoma	1.81e-05	5.83e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTGS2—glaucoma	1.66e-05	5.33e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NOS3—glaucoma	1.55e-05	4.98e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGS2—glaucoma	1.41e-05	4.55e-05	CbGpPWpGaD
